REGULATED PRESS RELEASE published on 02/18/2025 at 07:06, 1 year 4 months ago Edenred : Résultats annuels 2024
REGULATED PRESS RELEASE published on 02/18/2025 at 07:01, 1 year 4 months ago Edenred : Résultats annuels 2024
REGULATED PRESS RELEASE published on 02/18/2025 at 07:01, 1 year 4 months ago Edenred : 2024 annual results
REGULATED PRESS RELEASE published on 02/18/2025 at 07:00, 1 year 4 months ago Edenred : Résultats annuels 2024
REGULATED PRESS RELEASE published on 02/18/2025 at 07:00, 1 year 4 months ago Edenred : 2024 annual results
BRIEF published on 02/05/2025 at 10:35, 1 year 4 months ago Déclaration des Actions et Droits de Vote d'Edenred au 31 Janvier 2025 Droits De Vote Capital Social Investisseurs Informations Financières Actions Edenred
BRIEF published on 02/05/2025 at 10:35, 1 year 4 months ago EDENRED Announces Share Capital and Voting Rights Update Edenred Share Capital Voting Rights Financial Update 2025
REGULATED PRESS RELEASE published on 02/05/2025 at 10:30, 1 year 4 months ago Déclaration du nombre d’actions et droits de vote au 31 janvier 2025 Edenred déclare le nombre d'actions et de droits de vote conformément à la réglementation financière en vigueur Edenred Déclaration Droits De Vote Réglementation Financière Actions
REGULATED PRESS RELEASE published on 02/05/2025 at 10:30, 1 year 4 months ago Disclosure of Share Capital and Voting Rights as of January 31, 2025 Edenred discloses share capital and voting rights in accordance with French regulations. Check edenred.com for details Edenred Share Capital Voting Rights Investors French Regulations
BRIEF published on 01/17/2025 at 18:35, 1 year 5 months ago Mandat de rachat d'actions par Edenred Edenred Investissement Rachat D'actions Annulation D'actions Extension Mandat
Published on 06/27/2026 at 01:40, 2 hours 52 minutes ago Polaris Renewable Energy Announces Results of Director Elections at Annual and Special Meeting
Published on 06/27/2026 at 00:00, 4 hours 32 minutes ago Onco-Innovations Initiates Three-Species Hepatocyte and Microsome Metabolism Studies for ONC010
Published on 06/26/2026 at 23:00, 5 hours 32 minutes ago Canadian North Resources Inc. Announces Results of 2026 Annual General and Special Shareholders Meeting
Published on 06/26/2026 at 22:50, 5 hours 42 minutes ago Banyan Gold Files Technical Report for AurMac Project, Yukon, Canada
Published on 06/26/2026 at 22:15, 6 hours 17 minutes ago Revive Therapeutics Announces Proposed Private Placement
Published on 06/27/2026 at 00:05, 4 hours 27 minutes ago EAN Congress: Hearing aid use linked to 23% lower dementia risk in people with both epilepsy and hearing loss
Published on 06/27/2026 at 00:04, 4 hours 28 minutes ago Persistent and Nagarro sign Business Combination Agreement to form the Persistent - Nagarro Group, a global leader in AI-led digital engineering
Published on 06/26/2026 at 23:36, 4 hours 56 minutes ago Persistent and Nagarro sign Business Combination Agreement to form the Persistent – Nagarro Group, a global leader in AI-led digital engineering
Published on 06/26/2026 at 23:36, 4 hours 56 minutes ago EQS-Adhoc: Nagarro SE: Nagarro signs business combination agreement with Persistent Systems and supports voluntary public takeover offer to all shareholders at EUR 81 per share
Published on 06/26/2026 at 23:27, 5 hours 5 minutes ago EQS-WpÜG: Takeover Offer / Target company: Nagarro SE; Bidder: Galaxy Germany Holding SE
Published on 06/26/2026 at 17:45, 10 hours 47 minutes ago Descriptif du programme de rachat d'actions